EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY 4.0

Therapeutic Plasma Exchange in Critically Ill Children with Neuroimmunological Disorders: A Single-Center Cohort Study

Ebru G Sahin iD, Kubra B Guvenc iD, Gulcan A Yucel, Elif Yasar iD, Fatih Varol, Cansu Durak

Children · 09.07.2026 · 13 (7) · 908

DOI: 10.3390/children13070908 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Children, online erschienen am 09.07.2026. Verfasst von Ebru G Sahin und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Intensive Care, Sancaktepe Sehit Prof. Dr. Ilhan Varank Training and Research Hospital, University of Health Sciences, Istanb…. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Therapeutic plasma exchange (TPE) is increasingly used in pediatric neuroimmunological disorders; however, evidence remains limited, particularly for rare neuroinflammatory and infection-triggered encephalopathy syndromes. We aimed to describe the clinical characteristics, treatment patterns, and outcomes of critically ill children who underwent TPE for neuroimmunological disorders in a tertiary pediatric intensive care unit.

Methods

This retrospective observational study included consecutive patients younger than 18 years who received TPE for neuroimmunological disorders between September 2020 and December 2025. Demographic characteristics, disease spectrum, TPE indications, treatment details, neuroimaging findings, cerebrospinal fluid (CSF) characteristics, and clinical outcomes were reviewed. Neurological outcome at hospital discharge was assessed using the Pediatric Cerebral Performance Category (PCPC) score.

Results

Twenty-two patients were included. The median age was 104 months (IQR, 62.3–151.8), and 50% were female. Guillain–Barré syndrome (GBS) was the most common diagnosis (n = 6), followed by autoimmune encephalitis (n = 6), infection-triggered encephalopathy syndrome (ITES)/acute necrotizing encephalopathy (ANE) spectrum disorders (n = 4), myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) (n = 3), acute disseminated encephalomyelitis (ADEM) (n = 2), and mild encephalitis/encephalopathy with a reversible splenial lesion (MERS) (n = 1). The median interval from symptom onset to TPE initiation was 9 days (IQR, 6–13), and patients underwent a median of 7 TPE sessions (IQR, 5–10.5). Nine patients (40.9%) required invasive mechanical ventilation and four (18.1%) required vasoactive support. Favorable neurological outcomes at hospital discharge were observed in 63.6% of patients, whereas 36.4% had unfavorable neurological outcomes. Mortality occurred in 13.6% of patients and was confined to severe encephalopathic syndromes. No major TPE-related complications were observed.

Conclusions

TPE was used across a heterogeneous spectrum of pediatric neuroimmunological disorders, including both guideline-supported and non-standard indications. Approximately one-quarter of patients had conditions not specifically addressed in current ASFA recommendations, highlighting the gap between real-world clinical practice and the available evidence base. Multicenter studies are needed to better define the optimal role, timing, and patient selection criteria for TPE in pediatric neuroimmunology.

Schlagwörter

Stichwörter der Autor:innen

Guillain–Barré syndromeacute necrotizing encephalopathyautoimmune encephalitisinfection-triggered encephalopathy syndromepediatric critical carepediatric neuroimmunologytherapeutic plasma exchange

Autor:innen und Institutionen

  • Department of Pediatric Intensive Care, Sancaktepe Sehit Prof. Dr. Ilhan Varank Training and Research Hospital, University of Health Sciences, Istanbul 34785, Türkiye.
  • Department of Pediatric Neurology, Sancaktepe Sehit Prof. Dr. Ilhan Varank Training and Research Hospital, University of Health Sciences, Istanbul 34785, Türkiye.
  • Department of Pediatric Radiology, Sancaktepe Sehit Prof. Dr. Ilhan Varank Training and Research Hospital, University of Health Sciences, Istanbul 34785, Türkiye.

ORCID-Profile: Ebru G Sahin, Kubra B Guvenc, Elif Yasar

Zitieren

APA

Sahin, E. G., Guvenc, K. B., Yucel, G. A., Yasar, E., Varol, F., & Durak, C. (2026). Therapeutic Plasma Exchange in Critically Ill Children with Neuroimmunological Disorders: A Single-Center Cohort Study. Children, 13(7), 908. https://doi.org/10.3390/children13070908

Vancouver

Sahin EG, Guvenc KB, Yucel GA, Yasar E, Varol F, Durak C. Therapeutic Plasma Exchange in Critically Ill Children with Neuroimmunological Disorders: A Single-Center Cohort Study. Children. 2026;13(7):908. doi:10.3390/children13070908

BibTeX
@article{Sahin2026,
  author = {Sahin, Ebru G and Guvenc, Kubra B and Yucel, Gulcan A and Yasar, Elif and Varol, Fatih and Durak, Cansu},
  title = {Therapeutic Plasma Exchange in Critically Ill Children with Neuroimmunological Disorders: A Single-Center Cohort Study},
  journal = {Children},
  year = {2026},
  volume = {13},
  number = {7},
  pages = {908},
  doi = {10.3390/children13070908}
}
Kostenlos starten →